Elba A Turbat-Herrera1, Matthew J Kilpatrick1, Jie Chen1, Andrew T Meram2, James Cotelingam1, Ghali Ghali2, Christopher G Kevil1, Domenico Coppola3, Rodney E Shackelford4. 1. Department of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center, Shreveport, LA, U.S.A. 2. Head & Neck Oncologic/Microvascular Reconstructive Surgery Department of Oral & Maxillofacial/Head & Neck Surgery, Louisiana State University Health Sciences Center, Shreveport, LA, U.S.A. 3. Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, U.S.A. 4. Department of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center, Shreveport, LA, U.S.A. rshack@lsuhsc.edu.
Abstract
BACKGROUND: Cystathione β-synthase (CBS) catalyzes the conversion of homocysteine and cysteine to hydrogen sulfide (H2S) and cystathione, via the trans-sulfuration pathway. CBS protein expression levels are increased in several different human malignancies, with increased protein expression correlating with parameters such as tumor stage, anaplasia, metastases, and chemotherapy resistance. MATERIALS AND METHODS: This study employed tissue microarrays to examine CBS expression in benign thyroid tissue, thyroid oncocytomas, thyroid follicular adenomas, and in follicular, papillary, anaplastic, and medullary thyroid carcinomas. RESULTS: CBS expression was increased in all thyroid carcinomas types compared to benign thyroid tissue, but not in thyroid follicular adenomas or oncocytomas. A similar pattern was observed for nicotinamide phosphoribosyltransferase (NAMPT) tissue microarray analysis comparing thyroid adenomas and follicular carcinomas. CONCLUSION: For the first time, we showed that an H2S-syntheszing enzyme plays a role in thyroid malignancies. Additionally, our data suggest that CBS and NAMPT immunohistochemistry may be useful in differentiating follicular adenomas from follicular carcinomas. Copyright
BACKGROUND:Cystathione β-synthase (CBS) catalyzes the conversion of homocysteine and cysteine to hydrogen sulfide (H2S) and cystathione, via the trans-sulfuration pathway. CBS protein expression levels are increased in several different humanmalignancies, with increased protein expression correlating with parameters such as tumor stage, anaplasia, metastases, and chemotherapy resistance. MATERIALS AND METHODS: This study employed tissue microarrays to examine CBS expression in benign thyroid tissue, thyroid oncocytomas, thyroid follicular adenomas, and in follicular, papillary, anaplastic, and medullary thyroid carcinomas. RESULTS:CBS expression was increased in all thyroid carcinomas types compared to benign thyroid tissue, but not in thyroid follicular adenomas or oncocytomas. A similar pattern was observed for nicotinamide phosphoribosyltransferase (NAMPT) tissue microarray analysis comparing thyroid adenomas and follicular carcinomas. CONCLUSION: For the first time, we showed that an H2S-syntheszing enzyme plays a role in thyroid malignancies. Additionally, our data suggest that CBS and NAMPT immunohistochemistry may be useful in differentiating follicular adenomas from follicular carcinomas. Copyright
Authors: Rodney E Shackelford; Jehan Abdulsattar; Eric X Wei; James Cotelingam; Domenico Coppola; Guillermo A Herrera Journal: Anticancer Res Date: 2017-07 Impact factor: 2.480
Authors: Andrew T Meram; Jie Chen; Stavan Patel; Dongsoo D Kim; Brett Shirley; Paul Covello; Domenico Coppola; Eric X Wei; Ghali Ghali; Christopher G Kevil; Rodney E Shackelford Journal: Anticancer Res Date: 2018-07 Impact factor: 2.480
Authors: Patrícia Castro; Mette Eknaes; Manuel R Teixeira; Håvard E Danielsen; Paula Soares; Ragnhild A Lothe; Manuel Sobrinho-Simões Journal: J Pathol Date: 2005-07 Impact factor: 7.996
Authors: Sanjib Bhattacharyya; Sounik Saha; Karuna Giri; Ian R Lanza; K Sreekumar Nair; Nicholas B Jennings; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Eati Basal; Amy L Weaver; Daniel W Visscher; William Cliby; Anil K Sood; Resham Bhattacharya; Priyabrata Mukherjee Journal: PLoS One Date: 2013-11-13 Impact factor: 3.240
Authors: Ekin Ozluk; Domenico Coppola; Islam Z Mohammad; Tarif Islam; Ghali Ghali; Christopher G Kevil; Rodney E Shackelford Journal: Anticancer Res Date: 2021-10 Impact factor: 2.480